Vicks DayQuil NyQuil Combination Pack Recalled for Storage Temperature
Family Dollar Stores is recalling Vicks DayQuil/NyQuil Liquid combination packs (SKU 903367) distributed from April 30 to June 10, 2022, due to improper storage temperatures that may affect medication effectiveness.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This FDA Class II recall involves improper storage temperature of a medication, which poses a risk of reduced efficacy or stability. No illnesses or injuries have been reported, and the hazard remains theoretical, placing it in the high-risk category without documented harm.
Plain-English summary
Family Dollar Stores is recalling Vicks DayQuil/NyQuil Liquid Combination Pack 6 fluid ounce bottles (SKU 903367). The product was held outside appropriate storage temperature conditions, which constitutes a Current Good Manufacturing Practice (CGMP) deviation.
Medications stored at improper temperatures may lose potency or stability. This recall affects product distributed to Family Dollar Stores nationwide from April 30, 2022 through June 10, 2022.
Consumers who purchased this product should stop using it. Contact Family Dollar Stores for information about return or proper disposal. No illnesses or injuries have been reported in connection with this recall.
The recalled product
- Product
- VICKS DAYQUIL NYQUIL LIQ COMB PK 6 FLOZ distributed to specific Family Dollar Stores 04/30/2022 through 06/10/2022.
- Manufacturer
- Family Dollar Stores, Llc.
- Hazard
- improper-storage
- temperature-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- SKU: 903367
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27